Flotegatide F18Alternative Names: RGD F18
Latest Information Update: 08 Jan 2016
At a glance
- Originator Siemens Medical Solutions Molecular Imaging
- Developer Assistance Publique Hopitaux de Paris; Siemens Medical Solutions Molecular Imaging
- Class Peptide diagnostics; Peptides; Radiopharmaceutical diagnostics
- Mechanism of Action Integrin alphaVbeta3 modulators; Positron-emission tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cancer
- Preclinical Atherosclerosis